Health
GSK in talks to buy cancer biotech Nuvalent for more than $9bn
Key Points
A deal will rank as one of UK drugmaker’s biggest as biotech M&A activity accelerates this year
A deal will rank as one of UK drugmaker’s biggest as biotech M&A activity accelerates this year